Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Mais filtros










Intervalo de ano de publicação
6.
Lepr India ; 54(2): 270-4, 1982 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-7132296

RESUMO

PHA-induced blastoid transformation of lymphocytes was studied in 29 contacts of leprosy patients. 21 contacts taking DDS as prophylaxis showed significant depression of lymphocyte transformation while 8 contacts not taking DDS showed no depression as compared to controls. DDS thus has an inhibitory effect on cell mediated immune response.


Assuntos
Dapsona/uso terapêutico , Hanseníase/imunologia , Ativação Linfocitária/efeitos dos fármacos , Fito-Hemaglutininas/farmacologia , Humanos , Hanseníase/tratamento farmacológico
12.
Lepr India ; 53(2): 197-203, 1981 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-7253571

RESUMO

This paper presents a review of 123 cases of leprosy of different clinical types as regards to their status of cellular immunity. These 123 cases included 41 fresh cases, 18 cases of reaction and 64 cases of leprosy taking antileprosy treatment. Out of 41 untreated cases only 11 turned up for follow up and their lymphoblastic transformation was repeated 4 to 6 months after initiating the treatment. It was observed that cell mediated immunity as expressed in terms of percentage of blast cells is definitely depressed in leprosy, most in LL and least in TT. There is a definite increase in the percentage of blast cells after taking antileprosy treatment. The rise in percentage of blast cells and hence cellular immunity is relatively more in patients treated with Lamprene as compared to those treated with DDS. Reactions also have impact over immunity in leprosy. Thus, most of the patients with ENL show higher values for blast percentage as compared to those with lepra reaction. It appears that serial lymphocyte cultures if done in all cases of leprosy undergoing treatment will help in assessment of individual progress.


Assuntos
Imunidade Celular , Hanseníase/imunologia , Adolescente , Adulto , Criança , Clofazimina/farmacologia , Clofazimina/uso terapêutico , Dapsona/farmacologia , Dapsona/uso terapêutico , Feminino , Humanos , Imunidade Celular/efeitos dos fármacos , Hansenostáticos/farmacologia , Hansenostáticos/uso terapêutico , Hanseníase/tratamento farmacológico , Masculino
13.
s.l; s.n; apr. 1981. 7 p. tab, graf.
Não convencional em Inglês | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1240533

RESUMO

This paper presents a review of 123 cases of leprosy of different clinical types as regards to their status of cellular immunity. These 123 cases included 41 fresh cases, 18 cases of reaction and 64 cases of leprosy taking antileprosy treatment. Out of 41 untreated cases only 11 turned up for follow up and their lymphoblastic transformation was repeated 4 to 6 months after initiating the treatment. It was observed that cell mediated immunity as expressed in terms of percentage of blast cells is definitely depressed in leprosy, most in LL and least in TT. There is a definite increase in the percentage of blast cells after taking antileprosy treatment. The rise in percentage of blast cells and hence cellular immunity is relatively more in patients treated with Lamprene as compared to those treated with DDS. Reactions also have impact over immunity in leprosy. Thus, most of the patients with ENL show higher values for blast percentage as compared to those with lepra reaction. It appears that serial lymphocyte cultures if done in all cases of leprosy undergoing treatment will help in assessment of individual progress.


Assuntos
Masculino , Feminino , Humanos , Criança , Adulto , Adolescente , Clofazimina/farmacologia , Clofazimina/uso terapêutico , Dapsona/farmacologia , Dapsona/uso terapêutico , Hansenostáticos/farmacologia , Hansenostáticos/uso terapêutico , Hanseníase/imunologia , Hanseníase/tratamento farmacológico , Imunidade Celular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...